Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.50 is 78% above its 5-year average of -2.27, near the high end of its 5-year range (-6.90–-0.50).
34.21% above its 12-month average of -0.76.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.19.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.50
EARNINGS PER SHARE (EPS) AVG TTM
-0.76
EARNINGS PER SHARE (EPS) AVG 3Y
-1.17
EARNINGS PER SHARE (EPS) AVG 5Y
-2.27
EARNINGS PER SHARE (EPS) AVG 10Y
-142955.14
EARNINGS PER SHARE (EPS) AVG 15Y
-131810.37
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+34.21%
CURRENT VS 3Y AVG
+57.36%
CURRENT VS 5Y AVG
+77.97%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
N/A
InspireMD, Inc.
Market Cap
$28.10M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.76
3Y Avg
-1.17
5Y Avg
-2.27
Market Cap
$28.24M
Earnings Per Share (EPS)
-0.62
TTM Avg
-0.83
3Y Avg
-1.05
5Y Avg
-1.29
Market Cap
$27.89M
Earnings Per Share (EPS)
-2.41
TTM Avg
-9.11
3Y Avg
-20.57
5Y Avg
-19.82
Market Cap
$29.41M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
Market Cap
$29.60M
Earnings Per Share (EPS)
-1.87
TTM Avg
-12.30
3Y Avg
-40.98
5Y Avg
-45.74
Market Cap
$29.70M
Earnings Per Share (EPS)
-1.63
TTM Avg
-2.10
3Y Avg
-19.25
5Y Avg
-13.48
Market Cap
$29.88M
Earnings Per Share (EPS)
-4.31
TTM Avg
-4.75
3Y Avg
-350.99
5Y Avg
-43000.60
Market Cap
$29.96M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
Market Cap
$29.99M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.73
3Y Avg
-1.47
5Y Avg
-1.95
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $28.10M | -0.50 | -0.76 | -1.17 | -2.27 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.24M | -0.62 | -0.83 | -1.05 | -1.29 |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.89M | -2.41 | -9.11 | -20.57 | -19.82 |
| Context Therapeutics Inc. (CNTX)vs › | $29.41M | -0.48 | -0.42 | -0.82 | -1.14 |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | -1.87 | -12.30 | -40.98 | -45.74 |
| OneMedNet Corporation (ONMD)vs › | $29.70M | -1.63 | -2.10 | -19.25 | -13.48 |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | -4.31 | -4.75 | -350.99 | -43000.60 |
| BeyondSpring Inc. (BYSI)vs › | $29.96M | -0.17 | -0.24 | -0.47 | -0.92 |
| MDxHealth S.A. (MDXH)vs › | $29.99M | N/A | -0.73 | -1.47 | -1.95 |
| CervoMed Inc. (CRVO)vs › | $30.23M | -3.21 | -2.50 | -4.25 | -9.67 |
Trailing EPS (TTM)
$-0.50
Forward EPS (Est.)
$-0.61
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.76 |
| 2024-12-31 | -0.76 |
| 2023-12-31 | -0.82 |
| 2022-12-31 | -2.35 |
| 2021-12-31 | -2.03 |
| 2020-12-31 | -6.90 |
| 2019-12-31 | -72.00 |
| 2018-12-31 | -247.50 |
| 2017-12-31 | -4265.93 |
| 2016-12-31 | -151089.29 |
| 2015-12-31 | -1416818.18 |
| 2014-12-31 | -4182500.00 |
| 2013-06-30 | -5851600.00 |
| 2012-06-30 | -9217.92 |
| 2011-12-31 | -7332500.00 |
| 2010-06-30 | -3425.14 |
| 2009-06-30 | -956.25 |
